Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDegAsp vs BIAsp 30 in type 2 diabetes mellitus (China)
CTR20150689Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Apr 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of insulin degludec + insulin aspart in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Apr 2016; status: completed.
02
Drugs
insulin degludec + insulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20150689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150689.